Digital Presentation on Wednesday, September 16th at 3:00 PM EDT
Loma Linda, CA, Sept. 10, 2020 (GLOBE NEWSWIRE) — by way of NEWMEDIAWIRE — Aditx Therapeutics, Inc. (Aditxt) (the “Firm”) (NASDAQ:ADTX), a life sciences firm growing biotechnologies targeted on enhancing the well being of the immune system by means of immune monitoring and reprogramming, right this moment introduced that will probably be presenting on the H.C. Wainwright 22nd Annual World Funding Convention being held just about from September 14-16, 2020. The presentation is scheduled for Wednesday, September 16th at 3:00 PM EDT.
Amro Albanna, Co-founder and Chief Government Officer of Aditxt, shall be presenting a company overview to a reside viewers and shall be out there for digital one-on-one conferences with buyers all through the convention.
The presentation shall be webcast reside and could also be accessed by following this hyperlink: https://wsw.com/webcast/hcw7/adtx/1609577
About Aditx Therapeutics
Aditxt is growing applied sciences particularly targeted on enhancing the well being of the immune system by means of immune monitoring and reprogramming. The immune monitoring know-how is designed to supply a personalised complete profile of the immune system. The immune reprogramming know-how is at the moment on the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an goal of addressing rejection of transplanted organs, autoimmune illnesses, and allergic reactions. For extra data, please go to www.aditxt.com.
Sure statements on this press launch represent “forward-looking statements” inside the that means of the federal securities legal guidelines. Ahead-looking statements embrace statements relating to the Firm’s intentions, beliefs, projections, outlook, analyses or present expectations regarding, amongst different issues, the Firm’s ongoing and deliberate product growth; the Firm’s mental property place; the Firm’s potential to develop business capabilities; expectations relating to product launch and income; the Firm’s outcomes of operations, money wants, spending, monetary situation, liquidity, prospects, progress and techniques; the business by which the Firm operates; and the tendencies which will have an effect on the business or the Firm. Ahead-looking statements should not ensures of future efficiency and precise outcomes might differ materially from these indicated by these forward-looking statements because of varied necessary components, in addition to these dangers extra absolutely mentioned within the part entitled “Danger Elements” within the Firm’s prospectus, dated September 1, 2020, that was filed with the U.S. Securities and Alternate Fee underneath File No. 333-248491, in addition to discussions of potential dangers, uncertainties, and different necessary components within the Firm’s subsequent filings with the U.S. Securities and Alternate Fee. All such statements converse solely as of the date made, and the Firm undertakes no obligation to replace or revise publicly any forward-looking statements, whether or not because of new data, future occasions or in any other case.
Investor Relations Contact:
Chief Government Officer